Large-scale testing (Phase 3)UnknownNCT04047758What this trial is testingPalbociclib Combined With an Aromatase Inhibitor in Breast CancerWho this might be right forBreast Cancer Shengjing Hospital 420
Early research (Phase 1)WithdrawnNCT05905341What this trial is testingStudy of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.Who this might be right forBreast CancerOvarian CancerLiposarcoma+3 more Pfizer
Testing effectiveness (Phase 2)Study completedNCT04677595What this trial is testingStudy of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping MutationWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT02019277What this trial is testingPertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 50
Large-scale testing (Phase 3)Study completedNCT02284139What this trial is testingPilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side EffectsWho this might be right forNon-small Cell Lung CancerPancreatic CancerColorectal Cancer Dong-A University Hospital 90
Not applicableStudy completedNCT06686602What this trial is testingA Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast CancerWho this might be right forAdvanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer Daiichi Sankyo 13,759
Early research (Phase 1)Looking for participantsNCT07361237What this trial is testingA Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) MutationsWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Tongji University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07049926What this trial is testingSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 140
Large-scale testing (Phase 3)Study completedNCT03802240What this trial is testingSintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment FailureWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Innovent Biologics (Suzhou) Co. Ltd. 492
Testing effectiveness (Phase 2)Study completedNCT03717168What this trial is testingEffects of Growth Hormone on Difficult Ventilator Weaning PatientsWho this might be right forMechanical Ventilation Complication National Cancer Institute, Egypt 60
Testing effectiveness (Phase 2)WithdrawnNCT04781374What this trial is testingNeratinib in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Prostate AdenocarcinomaCastration-resistant Prostate CancerProstate Cancer+1 more Beth Israel Deaconess Medical Center
Not applicableUnknownNCT01317888What this trial is testingAccess Protocol for MAB-425 Radiolabeled With I-125 for High Grade GliomasWho this might be right forGlioblastoma MultiformeAstrocytoma Anaplastic Foci Drexel University 11
Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Testing effectiveness (Phase 2)WithdrawnNCT00048087What this trial is testingIressa/Docetaxel in Non-Small-Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01249521What this trial is testingDual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Austin Health 40
Testing effectiveness (Phase 2)WithdrawnNCT01288092What this trial is testingBEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT03656536What this trial is testingEvaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic CholangiocarcinomaWho this might be right forUnresectable CholangiocarcinomaMetastatic Cholangiocarcinoma Incyte Corporation 167
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400